VesCell Stem Cell Therapy for Heart Disease
VesCell adult stem cell therapy is used by cardiologists and vascular surgeons to treat heart disease for no-option patients suffering from Coronary Artery Disease (Coronary Heart Disease), Cardiomyopathy, and Congestive Heart Failure.
The adult stem cells are derived from the patient’s own blood, so there is no possibility of the body rejecting its own stem cells. This makes the procedure very safe.
Our adult stem cell therapy can relieve debilitating symptoms such as severe angina pectoris (chest pain), lack of energy and shortness of breath – and thereby reduce dependence on nitro tablets. Patients who have exhausted all other treatment options such as a cardiac artery bypass graft (CABG) or balloon angioplasties (PTCAs) are candidates.
VesCell stem cell therapy for heart disease can create new blood vessels that improve blood flow to the heart as well as generate new tissue in the heart muscle itself. The stem cell therapy leads to an increased ability to do everyday tasks, a noticeable increase in energy and hence an enhanced quality of life for the majority of our patients.
- Forums
- ASX - By Stock
- VCR
- stem cell
VCR
ventracor limited
stem cell, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online